A Potential Treatment for Idiopathic Pulmonary Fibrosis Earns Orphan Drug Designation
Pexels / Pixabay

A Potential Treatment for Idiopathic Pulmonary Fibrosis Earns Orphan Drug Designation

According to a story from Financial Buzz, the biotherapeutics company Bellerophon Therapeutics Inc. has recently announced that it has earned Orphan Drug designation from the US Food and Drug Administration…

Continue Reading A Potential Treatment for Idiopathic Pulmonary Fibrosis Earns Orphan Drug Designation
When is a yes a yes, and when is it an ‘I can’t say no’?  For Persons with Disabilities, Consent is Complicated
Catkin / Pixabay

When is a yes a yes, and when is it an ‘I can’t say no’? For Persons with Disabilities, Consent is Complicated

Consent is a concept back under discussion in modern conversations as we readdress what it means to cross the line. Consent is no longer seen in the black and white…

Continue Reading When is a yes a yes, and when is it an ‘I can’t say no’? For Persons with Disabilities, Consent is Complicated
New Data Highlights Zolgensma’s Benefits for Spinal Muscular Atrophy Patients
EliasSch / Pixabay

New Data Highlights Zolgensma’s Benefits for Spinal Muscular Atrophy Patients

According to a story from finanznachrichten.de, the latest data from three phase 3 studies is giving further confirmation to the capability of the recently approved gene therapy Zolgensma to have…

Continue Reading New Data Highlights Zolgensma’s Benefits for Spinal Muscular Atrophy Patients
Study Links Age of Onset and Year of Birth to Delayed Diagnosis for Hereditary Angioedema
mohamed_hassan / Pixabay

Study Links Age of Onset and Year of Birth to Delayed Diagnosis for Hereditary Angioedema

According to a study recently published in Allergy and Asthma Proceedings, certain risk factors may increase an individual's likelihood of receiving a late diagnosis for hereditary angioedema. Hereditary angioedema is…

Continue Reading Study Links Age of Onset and Year of Birth to Delayed Diagnosis for Hereditary Angioedema

A Cystinosis Story: No Patient Should Have to Fight for Access to Their Medication

Cystinosis Cystinosis is a rare disease that causes cystine, an amino acid, to build up in the body's organs. However, there is treatment that can prevent this accumulation. Normally, patients…

Continue Reading A Cystinosis Story: No Patient Should Have to Fight for Access to Their Medication
Close Menu